Search Results - "Jonges, L"

Refine Results
  1. 1
  2. 2
  3. 3

    Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not? by Vannini, A, Cheung, K, Fusconi, M, Stammen-Vogelzangs, J, Drenth, J P H, Dall’Aglio, A C, Bianchi, F B, Bakker-Jonges, L E, van Venrooij, W J, Pruijn, G J M, Zendman, A J W

    Published in Annals of the rheumatic diseases (01-04-2007)
    “…Background: Antibodies directed against citrullinated proteins (eg anti-cyclic citrullinated peptide (CCP)) have excellent diagnostic and good prognostic…”
    Get full text
    Journal Article
  4. 4

    B-cell maturation and antibody responses in individuals carrying a mutated CD19 allele by Artac, H, Reisli, I, Kara, R, Pico-Knijnenburg, I, Adin-Çinar, S, Pekcan, S, Jol-van der Zijde, C M, van Tol, M J D, Bakker-Jonges, L E, van Dongen, J J M, van der Burg, M, van Zelm, M C

    Published in Genes and immunity (01-10-2010)
    “…Homozygous CD19 mutations lead to an antibody deficiency due to disruption of the CD19 complex and consequent impaired signaling by the B-cell antigen…”
    Get full text
    Journal Article
  5. 5

    Recombinant adenoviral vectors have adjuvant activity and stimulate T cell responses against tumor cells by GEUTSKENS, S. B, VAN DER EB, M. M, PLOMP, A. C, JONGES, L. E, CRAMER, S. J, ENSINK, N. G, KUPPEN, P. J. K, HOEBEN, R. C

    Published in Gene therapy (01-08-2000)
    “…The host-immune response against adenoviruses forms a major obstacle for their use as gene therapy vectors for treatment of genetic defects. None the less,…”
    Get full text
    Journal Article
  6. 6

    Efficient direct priming of tumor-specific cytotoxic T lymphocyte in vivo by an engineered APC by SCHOENBERGER, S. P, JONGES, L. E, MOOIJAART, R. J. D, HARTGERS, F, TOES, R. E. M, KAST, W. M, MELIEF, C. J. M, OFFRINGA, R

    Published in Cancer research (Chicago, Ill.) (15-07-1998)
    “…Although numerous studies have documented a role for B7-1 (CD80) in the induction of antitumor CTL immunity, it is presently unclear to what extent expression…”
    Get full text
    Journal Article
  7. 7

    The Phenotypic Heterogeneity of Human Natural Killer Cells: Presence of at least 48 Different Subsets in the Peripheral Blood by Jonges, L. E., Albertsson, P., Van Vlierberghe, R. L. P., Ensink, N. G., Johansson, B. R., Van De Velde, C. J. H., Fleuren, G. J., Nannmark, U., Kuppen, P. J. K.

    Published in Scandinavian journal of immunology (01-02-2001)
    “…Peripheral blood natural killer (NK) cells are usually defined as a homogeneous cell population. However, NK cells show heterogeneous expression of a diversity…”
    Get full text
    Journal Article
  8. 8

    Caspase-3 Activity as a Prognostic Factor in Colorectal Carcinoma by Jonges, Liesbeth E, Nagelkerke, J Fred, Ensink, N Geeske, van der Velde, Edo A, Tollenaar, Rob A E M, Fleuren, Gert Jan, van de Velde, Cornelis J H, Morreau, Hans, Kuppen, Peter J K

    Published in Laboratory investigation (01-05-2001)
    “…Several techniques to determine apoptotic frequencies in tumors have been described. In this study, we report that biochemical detection of enzymatic caspase-3…”
    Get full text
    Journal Article
  9. 9

    Matrix metalloproteinases of human NK cells by Albertsson, P, Kim, M H, Jonges, L E, Kitson, R P, Kuppen, P J, Johansson, B R, Nannmark, U, Goldfarb, R H

    Published in In vivo (Athens) (01-01-2000)
    “…We have previously reported that MMP-2 and MMP-9 are present in rat A-NK cells, and have recently documented that additional MMPs are present in rodent A-NK…”
    Get more information
    Journal Article
  10. 10

    Liver and tumour tissue concentrations of TNF-alpha in cancer patients treated with TNF-alpha and melphalan by isolated liver perfusion by KUPPEN, PJK, JONGES, LE, VAN DE VELDE, CJH, VAHRMEIJER, AL, TOLLENAAR, RAEM, BOREL RINKES, IHM, EGGERMONT, AMM

    Published in British journal of cancer (1997)
    “…In this study we determined the level of tumour necrosis factor alpha (TNF-alpha) in liver and tumour tissue samples obtained from patients with colorectal…”
    Get full text
    Journal Article
  11. 11

    Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer by Kuppen, P J, van der Eb, M M, Jonges, L E, Hagenaars, M, Hokland, M E, Nannmark, U, Goldfarb, R H, Basse, P H, Fleuren, G J, Hoeben, R C, van de Velde, C J

    Published in Histochemistry and cell biology (01-01-2001)
    “…In this article we report about the role that tumor structure and extracellular matrix (ECM) may play in immunotherapy and in gene therapy using adenoviruses…”
    Get full text
    Journal Article
  12. 12

    Role of NK cells in adoptive immunotherapy of metastatic colorectal cancer in a syngeneic rat model by Kuppen, Peter J. K., Gorter, Arko, Hagenaars, Martin, Jonges, Liesbeth E., Giezeman-Smits, Katinka M., Nagelkerke, J. Fred, Fleuren, Gertjan, Van De Velde, Cornelis J. H.

    Published in Immunological reviews (01-12-2001)
    “…This article reviews our immunotherapy research with natural killer (NK) cells in a syngeneic rat colorectal cancer liver and lung metastasis model. Using…”
    Get full text
    Journal Article
  13. 13
  14. 14

    NK Cells Modulate MHC Class I Expression on Tumor Cells and their Susceptibility to Lysis by Jonges, Liesbeth E., Giezeman-Smits, Katinka M., Van Vlierberghe, Ronald LP, Ensink, NGeeske, Hagenaars, Martin, Joly, étienne, Eggermont, Alexander MM, Van De Velde, Cornelis JH, Fleuren, Gert Jan, Kuppen, Peter JK

    Published in Immunobiology (1979) (01-11-2000)
    “…Cytotoxicity and production of cytokines are two important functions of NK cellsThese two different NK functions were studied in a syngeneic rat model in…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis by Bakker-Jonges, L E, ter Borg, P C J, van Buuren, H R, Hooijkaas, H

    Published in Nederlands tijdschrift voor geneeskunde (04-03-2006)
    “…To determine the diagnostic value of antibodies against soluble liver antigen (anti-SLA antibodies) and a number of other antibodies for the diagnosis…”
    Get more information
    Journal Article
  18. 18

    The development of a bi-specific anti-CD161A x anti-tumor antibody for rat NK cell targeting by Hagenaars, M, Ensink, N G, Jonges, L E, Chambers, W H, Eggermont, A M, van de Velde, C J, Fleuren, G J, Kuppen, P J

    Published in Immunobiology (1979) (01-02-1999)
    “…In order to improve the therapeutic efficacy of adoptive immunotherapy of cancer using IL-2-activated NK (A-NK) cells, we developed a bi-specific monoclonal…”
    Get full text
    Journal Article
  19. 19
  20. 20